Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BCBA/NVS stock hub

BCBA/NVS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/NVSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

387.4T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/NVS

In the news

Latest news · BCBA/NVS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.2

P25 n/aP50 n/aP75 n/a

Trailing P/E20.7

P25 n/aP50 n/aP75 n/a

ROE34.9

P25 n/aP50 n/aP75 n/a

ROIC21.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/NVS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	AR
Employees	75,267
Employees Change	-616%
Employees Change Percent	-0.81
Enterprise value	ARS 445.7T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	ARS 387.4T
Price	ARS 54,400
Price currency	ARS
Rev Per Employee	1,038,480,105.74x
Sic	2834
Symbol	bcba/NVS
Website	https://www.novartis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.83%
EV Earnings	23.84x
EV/EBIT	16.85x
EV/EBITDA	13.37x
EV/FCF	18.4x
EV/Sales	5.48x
FCF yield	6.25%
Forward P/E	16.23x
P/B ratio	7.2x
P/E ratio	20.72x
P/S ratio	4.96x
PE Ratio10 Y	20.03x
PE Ratio3 Y	18.04x
PE Ratio5 Y	17.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.56%
EBITDA Margin	40.51%
FCF margin	30.99%
Gross margin	75.55%
Gross Profit	ARS 59.1T
Gross Profit Growth	6.14%
Gross Profit Growth Q	-2.95%
Gross Profit Growth3 Y	10.99%
Gross Profit Growth5 Y	3.98%
Net Income	ARS 18.7T
Net Income Growth	5.25%
Net Income Growth Q	-12.48%
Net Income Growth3 Y	24.42%
Net Income Growth5 Y	11.21%
Pretax Margin	27.9%
Profit Margin	23.92%
Profit Per Employee	ARS 248.4M
ROA	10.54
Roa5y	7.4
ROCE	21.14
ROE	34.93
Roe5y	23.91
ROIC	21.1
Roic5y	17.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	71.86%
Cagr3y	69.28%
Cagr5y	76.16%
Div CAGR10	34.36%
Div CAGR3	28.65%
Div CAGR5	80.51%
EPS Growth	9.48
EPS Growth Q	-9.34
EPS Growth3 Y	29.06
EPS Growth5 Y	14.94
FCF Growth	-0.4%
FCF Growth Q	-1.8%
FCF Growth3 Y	6.01%
FCF Growth5 Y	7.94%
OCF Growth	0.93%
OCF Growth Q	0.85%
OCF Growth10 Y	5.03%
OCF Growth3 Y	7.25%
OCF Growth5 Y	7.67%
Revenue Growth	6.31x
Revenue Growth Q	-0.71x
Revenue Growth3 Y	10.71x
Revenue Growth5 Y	2.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.52
Assets	ARS 163.8T
Cash	ARS 9.5T
Current Assets	ARS 37.2T
Current Liabilities	ARS 43.9T
Debt	ARS 64.9T
Debt EBITDA	ARS 2.03
Debt Equity	ARS 1.21
Debt FCF	ARS 2.68
Equity	ARS 53.8T
Interest Coverage	15.14
Liabilities	ARS 110T
Long Term Assets	ARS 126.5T
Long Term Liabilities	ARS 66.1T
Net Cash	ARS -55.4T
Net Cash By Market Cap	ARS -14.3
Net Debt EBITDA	ARS 1.75
Net Debt Equity	ARS 1.03
Net Debt FCF	ARS 2.29
Tangible Book Value	ARS -39.4T
Tangible Book Value Per Share	ARS -20,646

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.85
Inventory Turnover	2.28
Net Working Capital	ARS -5.2T
Quick ratio	0.53
Working Capital	ARS -6.6T
Working Capital Turnover	ARS -13,861

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.8%
Dividend Growth	58.23%
Dividend Growth Years	3%
Dividend per share	ARS 988
Dividend Years	3
Dividend Yield	1.83%
Ex Div Date	2026-03-11
Last Dividend	ARS 988
Payout Frequency	Annual
Payout Ratio	64.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	71.79%
200-day SMA	50,449.1
3Y total return	385.25%
50-day SMA	56,492
50-day SMA vs 200-day SMA	50over200
5Y total return	1,595.75%
All Time High	63,200
All Time High Change	-13.81%
All Time High Date	2026-02-27
All Time Low	1,961
All Time Low Change	2,677.92%
All Time Low Date	2020-01-27
ATR	914.3
Ch YTD	2.64
High	54,475
High52	63,200
High52 Date	2026-02-27
High52ch	-13.92%
Low	54,150
Low52	30,425
Low52 Date	2025-05-14
Low52ch	78.8%
Ma50ch	-3.57%
Price vs 200-day SMA	7.98%
RSI	45.97
RSI Monthly	67.52
RSI Weekly	53.13
Sharpe ratio	1.71x
Sortino ratio	2.75
Total Return	5.63%
Tr YTD	5.6
Tr1m	-2.81%
Tr1w	0.28%
Tr3m	-3.99%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ARS 25.5T
Operating Income Growth	4.47
Operating Income Growth Q	-12.37
Operating Income Growth3 Y	20.99
Operating Income Growth5 Y	10.06
Operating margin	32.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,816,121,384%
Net Borrowing	20,316,904,902,342
Shares Insiders	0.11%
Shares Institutions	44.44%
Shares Qo Q	-0.67%
Shares Yo Y	-3.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 22.7T
Average Volume	249.1x
Bv Per Share	27,883.8
CAPEX	ARS -2.3T
Ch1m	-2.81
Ch1w	0.28
Ch1y	66.97
Ch3m	-6.68
Ch3y	354.8
Ch5y	1,469.9
Ch6m	16.75
Change	0.74%
Change From Open	-0.05
Close	54,000
Days Gap	0.79
Depreciation Amortization	6,292,561,968,583
Dollar Volume	45,587,200
Earnings Date	2026-04-28
EBIT	ARS 25.5T
EBITDA	ARS 31.7T
EPS	ARS 9,644
F Score	5
FCF	ARS 24.2T
FCF EV Yield	5.44x
Financing CF	-3,785,347,538,000
Fiscal Year End	December
Founded	1,996
Goodwill	37,510,606,676,023
Graham Number	21148.6518
Graham Upside	-61.18
Income Tax	ARS 3.1T
Investing CF	-23,406,986,619,100
Is Primary Listing	0
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2020-10-22
Last Split Type	Forward
Lynch Fair Value	ARS 29,479
Lynch Upside	-45.88
Ma150	53,405.6
Ma150ch	2%
Ma20	54,906.3
Ma20ch	-0.79%
Net CF	-261,106,089,300
Next Earnings Date	2026-07-21
Open	54,425
P FCF Ratio	15.99
P OCF Ratio	14.63
Payment Date	2026-03-16
Position In Range	76.92
Ppne	17,116,775,588,246
Price Date	2026-05-08
Price EBITDA	ARS 12.23
Relative Volume	3.36x
Revenue	78,163,282,118,600x
SBC By Revenue	2.01x
Share Based Comp	1,570,781,076,900
Tax By Revenue	4.01x
Tax Rate	14.38%
Tr6m	20.12%
Volume	838
Z Score	3.27

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BCBA/NVS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$988 annual per share

Payout ratio

+64.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+80.5%

3 consecutive years of growth

Total shareholder yield

+5.6%

Next ex-dividend date: 2026-03-11

Performance

BCBA/NVS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCBA/NVS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.4%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-3.8%

Negative means the company is buying back shares.

Technical

BCBA/NVS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.0

Neutral momentum band

Price vs 200-day MA

+8.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/NVS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/NVS stock rating?

bcba/NVS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/NVS analysis?

The full report lives at /stocks/bcba/NVS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/NVS?

The latest report frames bcba/NVS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/NVS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.